Management ChangeApr 24, 2026, 04:37 PM
Onconetix Board Sees Director Resignations, New Chairman & Director
AI Summary
Onconetix, Inc. announced several changes to its Board of Directors. Andrew Oakley and Thomas Meier resigned from the Board, with Oakley also stepping down as Chairman and from various committees. The company appointed existing board member Sammy Dorf as the new Chairman, who will receive an annual compensation of $20,000. Additionally, Josh Epstein was elected as a new Class II director, joining the Audit and Compensation Committees and chairing the Nominating and Corporate Governance Committee.
Key Highlights
- Andrew Oakley and Thomas Meier resigned from Onconetix's Board effective April 20, 2026.
- Oakley also resigned as Chairman and from the Audit, Compensation, and Nominating committees.
- Sammy Dorf, an existing board member, was appointed Chairman effective April 23, 2026.
- Mr. Dorf will receive an annual compensation of $20,000, payable quarterly.
- Josh Epstein was elected as a new Class II director effective April 23, 2026, joining key committees.